Soraya Bekkali

Soraya Bekkali

Soraya Bekkali, MD, Alexion, AstraZeneca Rare Disease Senior Vice President, EUCAN and International Region

Europe's next chapter for Orphan Innovation: science alone isn't enough Partner Content
10 Apr Member States
Europe's next chapter for Orphan Innovation: science alone isn't enough
A strong foundation exists, but protecting decades of progress will require renewed commitments to deliver innovation and access to patients at both EU and national levels
For patients with rare diseases, European public health policies must work harder Partner Content
28 Sep 23
For patients with rare diseases, European public health policies must work harder
Policies must ensure health equity for rare disease patients the European Union to ensure that they have equal access to diagnosis and treatments.